Search Results - Amanda Clarke
- Showing 1 - 20 results of 34
- Go to Next Page
-
1
Understanding and achieving person‐centred care: the nurse perspective by Helen J. Ross, Angela Tod, Amanda Clarke
Published 2014Artigo -
2
-
3
-
4
-
5
Patient-Reported Symptoms Over 48 Weeks Among Participants in Randomized, Double-Blind, Phase III Non-inferiority Trials of Adults with HIV on Co-formulated Bictegravir, Emtricitab... by David A. Wohl, Amanda Clarke, Franco Maggiolo, Will Garner, Marianne Laouri, Hal Martin, Erin Quirk
Published 2018Artigo -
6
“I Try and Smile, I Try and Be Cheery, I Try Not to Be Pushy. I Try to Say ‘I'm Here for Help’ but I Leave Feeling… Worried”: A Qualitative Study of Perceptions of Interactions wit... by Amanda Clarke, Denis Martin, Derek K. Jones, Patricia Schofield, Geraldine Anthony, Paul McNamee, Denise Gray, Blair H. Smith
Published 2014Artigo -
7
Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From... by Frank A. Post, Pablo Tebas, Amanda Clarke, Laurent Cotte, William R. Short, Michael E. Abram, Shuping Jiang, Andrew Cheng, Moupali Das, Marshall W. Fordyce
Published 2016Artigo -
8
Effects of Neutral Endopeptidase (Neprilysin) Inhibition on the Response to Other Vasoactive Peptides in Small Human Resistance Arteries: Studies with Thiorphan and Omapatrilat by Jonathan R. Dalzell, Alison Seed, Colin Berry, Carol Whelan, Mark C. Petrie, Neal Padmanabhan, Amanda Clarke, Fiona Biggerstaff, Christopher Hillier, John J.V. McMurray
Published 2013Artigo -
9
Changes in recreational drug use, drug use associated with chemsex, and HIV-related behaviours, among HIV-negative men who have sex with men in London and Brighton, 2013–2016 by Janey Sewell, Valentina Cambiano, Ada Miltz, Andrew Speakman, Fiona Lampe, Andrew Phillips, David Stuart, Richard Gilson, David Asboe, Nneka Nwokolo, Amanda Clarke, Graham Hart, Alison Rodger
Published 2018Artigo -
10
Poly drug use, chemsex drug use, and associations with sexual risk behaviour in HIV-negative men who have sex with men attending sexual health clinics by Janey Sewell, Ada Miltz, Fiona Lampe, Valentina Cambiano, Andrew Speakman, Andrew Phillips, David Stuart, Richard Gilson, David Asboe, Nneka Nwokolo, Amanda Clarke, Simon Collins, Graham Hart, Jonathan Elford, Alison Rodger
Published 2017Artigo -
11
Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a ran... by David A. Wohl, Yazdan Yazdanpanah, Axel Baumgarten, Amanda Clarke, Melanie Thompson, Cynthia Brinson, Debbie Hagins, Moti Ramgopal, Andrea Antinori, Xuelian Wei, Rima Acosta, Sean E Collins, Diana M. Brainard, Hal Martin
Published 2019Artigo -
12
Pharmacokinetic and Pharmacodynamic Comparison of Once‐Daily Efavirenz (400 mg vs. 600 mg) in Treatment‐Naïve HIV‐Infected Patients: Results of the ENCORE1 Study by Laura Dickinson, Janaki Amin, Laura Else, Marta Boffito, Deirdre Egan, Andrew Owen, SH Khoo, David Back, Catherine Orrell, Amanda Clarke, Marcelo Losso, Praphan Phanuphak, Dianne Carey, D. A. Cooper, Sean Emery, Rebekah Puls
Published 2015Artigo -
13
Comprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600 mg in Treatment-Naïve HIV-Infected Patients at 96 Weeks: Results o... by Laura Dickinson, Janaki Amin, Laura Else, Marta Boffito, Deirdre Egan, Andrew Owen, Saye Khoo, David Back, Catherine Orrell, Amanda Clarke, Marcelo Losso, Praphan Phanuphak, Dianne Carey, David A. Cooper, Sean Emery, Rebekah Puls
Published 2015Artigo -
14
Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults by François Raffi, Chloe Orkin, Amanda Clarke, Laurence Slama, Joel E. Gallant, Eric S. Daar, Keith Henry, Jorge Santana‐Bagur, David Stein, Nicholaos Bellos, Anthony Scarsella, Mingjin Yan, Michael E. Abram, Andrew Cheng, Martin S. Rhee
Published 2017Artigo -
15
Patient-Reported Outcomes After Switching to a 2-Drug Regimen of Fixed-Dose Combination Dolutegravir/Lamivudine: 48-Week Results from the SALSA Study by Princy Kumar, Amanda Clarke, Celia Jonsson‐Oldenbüttel, Miguel García Deltoro, Simona Di Giambenedetto, Carlos Brites, Laurent Hocqueloux, Po‐Liang Lu, J Oyee, Alan Oglesby, Brian Wynne, Bryn Jones, Lee Evitt, Dainielle Fox, Michelle Kisare, Julie Priest
Published 2024Artigo -
16
The Context of Sexual Risk Behaviour Among Men Who Have Sex with Men Seeking PrEP, and the Impact of PrEP on Sexual Behaviour by Mitzy Gafos, Rob Horne, Will Nutland, Gill Bell, Caroline Rae, Sonali Wayal, Michael Rayment, Amanda Clarke, Gabriel Schembri, Richard Gilson, Alan McOwan, Ann Sullivan, Julie Fox, Vanessa Apea, Claire Dewsnap, David Dolling, Ellen White, Elizabeth Brodnicki, Gemma Wood, David Dunn, Sheena McCormack
Published 2018Artigo -
17
Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled S... by Ken M. Kunisaki, Dennis E. Niewoehner, Gary Collins, Bitten Aagaard, Nafisah B. Atako, Elżbieta Bąkowska, Amanda Clarke, Giulio Maria Corbelli, Ernest Ekong, Sean Emery, Elizabeth B. Finley, Éric Florence, Rosa Infante, Cissy Kityo, Juan Sierra Madero, Daniel E. Nixon, Ellen Tedaldi, Jørgen Vestbo, Robin Wood, John E. Connett
Published 2016Artigo -
18
Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from... by Chloe Orkin, Edwin DeJesus, Paul E. Sax, José Ramón Arribas, Samir K. Gupta, Claudia Martorell, Jeffrey L. Stephens, Hans‐Jürgen Stellbrink, David A. Wohl, Franco Maggiolo, Melanie Thompson, Daniel Podzamczer, Debbie Hagins, Jason Flamm, Cynthia Brinson, Amanda Clarke, Hailin Huang, Rima Acosta, Diana M. Brainard, Sean E Collins, Hal Martin
Published 2020Artigo -
19
An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis by David Dolling, Monica Desai, Alan McOwan, Richard Gilson, Amanda Clarke, Fabiola Martin, Gabriel Schembri, Ann Sullivan, Nicola Mackie, Iain Reeves, Mags Portman, John Saunders, Julie Fox, Jake Bayley, Michael Brady, Christine Bowman, Charles Lacey, Stephen Taylor, David White, Simone Antonucci, Mitzy Gafos, Sheena McCormack, O N Gill, David Dunn, Anthony Nardone
Published 2016Artigo -
20
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial by Sheena McCormack, David Dunn, Monica Desai, David Dolling, Mitzy Gafos, Richard Gilson, Ann Sullivan, Amanda Clarke, Iain Reeves, Gabriel Schembri, Nicola Mackie, Christine Bowman, Charles Lacey, Vanessa Apea, Michael Brady, Julie Fox, Stephen Taylor, Simone Antonucci, Saye Khoo, James F. Rooney, Anthony Nardone, Martin Fisher, Alan McOwan, Andrew Phillips, Margaret Johnson, Brian Gazzard, O N Gill
Published 2015Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Human immunodeficiency virus (HIV)
Viral load
Antiretroviral therapy
Biology
Randomized controlled trial
Virology
Emtricitabine
Family medicine
Gene
Nursing
Pharmacology
Tenofovir alafenamide
Genetics
Men who have sex with men
Psychology
Sociology
Syphilis
Cancer
Cancer research
Environmental health
Mutation
Pathology
Population
Demography
Dolutegravir
Gastroenterology
Immunology
Physics